These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
396 related articles for article (PubMed ID: 17254746)
1. Activity, toxicity and analysis of resistance of essential oil from Chenopodium ambrosioides after intraperitoneal, oral and intralesional administration in BALB/c mice infected with Leishmania amazonensis: a preliminary study. Monzote L; Montalvo AM; Scull R; Miranda M; Abreu J Biomed Pharmacother; 2007; 61(2-3):148-53. PubMed ID: 17254746 [TBL] [Abstract][Full Text] [Related]
2. Effect of oral treatment with the essential oil from Chenopodium ambrosioides against cutaneous leishmaniasis in BALB/c mice, caused by Leishmania amazonensis. Monzote L; García M; Montalvo AM; Linares R; Scull R Forsch Komplementmed; 2009 Oct; 16(5):334-8. PubMed ID: 19887812 [TBL] [Abstract][Full Text] [Related]
3. Activity of the essential oil from Chenopodium ambrosioides grown in Cuba against Leishmania amazonensis. Monzote L; Montalvo AM; Almanonni S; Scull R; Miranda M; Abreu J Chemotherapy; 2006; 52(3):130-6. PubMed ID: 16636536 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of the intralesional treatment with Chenopodium ambrosioides in the murine infection by Leishmania amazonensis. Patrício FJ; Costa GC; Pereira PV; Aragão-Filho WC; Sousa SM; Frazão JB; Pereira WS; Maciel MC; Silva LA; Amaral FM; Rebêlo JM; Guerra RN; Ribeiro MN; Nascimento FR J Ethnopharmacol; 2008 Jan; 115(2):313-9. PubMed ID: 18035510 [TBL] [Abstract][Full Text] [Related]
5. Antileishmanial activity of essential oil from Chenopodium ambrosioides and its main components against experimental cutaneous leishmaniasis in BALB/c mice. Monzote L; Pastor J; Scull R; Gille L Phytomedicine; 2014; 21(8-9):1048-52. PubMed ID: 24768411 [TBL] [Abstract][Full Text] [Related]
6. Comparative chemical, cytotoxicity and antileishmanial properties of essential oils from Chenopodium ambrosioides. Monzote L; Nance MR; García M; Scull R; Setzer WN Nat Prod Commun; 2011 Feb; 6(2):281-6. PubMed ID: 21425695 [TBL] [Abstract][Full Text] [Related]
7. Combined effect of the essential oil from Chenopodium ambrosioides and antileishmanial drugs on promastigotes of Leishmania amazonensis. Monzote L; Montalvo AM; Scull R; Miranda M; Abreu J Rev Inst Med Trop Sao Paulo; 2007; 49(4):257-60. PubMed ID: 17823757 [TBL] [Abstract][Full Text] [Related]
8. In vitro activity of an essential oil against Leishmania donovani. Monzote L; García M; Montalvo AM; Scull R; Miranda M; Abreu J Phytother Res; 2007 Nov; 21(11):1055-8. PubMed ID: 17724767 [TBL] [Abstract][Full Text] [Related]
9. Essential oil from Chenopodium ambrosioides and main components: activity against Leishmania, their mitochondria and other microorganisms. Monzote L; García M; Pastor J; Gil L; Scull R; Maes L; Cos P; Gille L Exp Parasitol; 2014 Jan; 136():20-6. PubMed ID: 24184772 [TBL] [Abstract][Full Text] [Related]
10. Leishmania amazonensis: effects of oral treatment with copaiba oil in mice. dos Santos AO; Costa MA; Ueda-Nakamura T; Dias-Filho BP; da Veiga-Júnior VF; de Souza Lima MM; Nakamura CV Exp Parasitol; 2011 Oct; 129(2):145-51. PubMed ID: 21771592 [TBL] [Abstract][Full Text] [Related]
11. Combinations of ascaridole, carvacrol, and caryophyllene oxide against Leishmania. Pastor J; García M; Steinbauer S; Setzer WN; Scull R; Gille L; Monzote L Acta Trop; 2015 May; 145():31-8. PubMed ID: 25697866 [TBL] [Abstract][Full Text] [Related]
12. In vitro antileishmanial activity and cytotoxicity of essential oil from Lippia sidoides Cham. de Medeiros Md; da Silva AC; Citó AM; Borges AR; de Lima SG; Lopes JA; Figueiredo RC Parasitol Int; 2011 Sep; 60(3):237-41. PubMed ID: 21421075 [TBL] [Abstract][Full Text] [Related]
13. Effect of imidocarb and levamisole on the experimental infection of BALB/c mice by Leishmania (Leishmania) amazonensis. Rodrigues FH; Afonso-Cardoso SR; Gomes MA; Beletti ME; Rocha A; Guimarães AH; Candeloro I; de Souza MA Vet Parasitol; 2006 Jun; 139(1-3):37-46. PubMed ID: 16647821 [TBL] [Abstract][Full Text] [Related]
14. Tamoxifen as a potential antileishmanial agent: efficacy in the treatment of Leishmania braziliensis and Leishmania chagasi infections. Miguel DC; Zauli-Nascimento RC; Yokoyama-Yasunaka JK; Katz S; Barbiéri CL; Uliana SR J Antimicrob Chemother; 2009 Feb; 63(2):365-8. PubMed ID: 19095684 [TBL] [Abstract][Full Text] [Related]
15. Effect of Brazilian copaiba oils on Leishmania amazonensis. Santos AO; Ueda-Nakamura T; Dias Filho BP; Veiga Junior VF; Pinto AC; Nakamura CV J Ethnopharmacol; 2008 Nov; 120(2):204-8. PubMed ID: 18775772 [TBL] [Abstract][Full Text] [Related]
16. In vivo activity of perifosine against Leishmania amazonensis. Cabrera-Serra MG; Valladares B; Piñero JE Acta Trop; 2008 Oct; 108(1):20-5. PubMed ID: 18801328 [TBL] [Abstract][Full Text] [Related]
17. Antileishmanial activity of a tetralone isolated from Ampelocera edentula, a Bolivian plant used as a treatment for cutaneous leishmaniasis. Fournet A; Barrios AA; Muñoz V; Hocquemiller R; Roblot F; Cavé A Planta Med; 1994 Feb; 60(1):8-12. PubMed ID: 8134421 [TBL] [Abstract][Full Text] [Related]
18. The in vivo activity of 1,3,4-thiadiazolium-2-aminide compounds in the treatment of cutaneous and visceral leishmaniasis. Rodrigues RF; Charret KS; Campos MC; Amaral V; Echevarria A; Dos Reis C; Canto-Cavalheiro MM; Leon LL J Antimicrob Chemother; 2012 Jan; 67(1):182-90. PubMed ID: 21987238 [TBL] [Abstract][Full Text] [Related]
19. Antileishmanial activity of the essential oil from Bixa orellana. Monzote L; García M; Scull R; Cuellar A; Setzer WN Phytother Res; 2014 May; 28(5):753-8. PubMed ID: 23983115 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of miltefosine treatment in Leishmania amazonensis-infected BALB/c mice. Godinho JL; Simas-Rodrigues C; Silva R; Ürmenyi TP; de Souza W; Rodrigues JC Int J Antimicrob Agents; 2012 Apr; 39(4):326-31. PubMed ID: 22226653 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]